Abstract
In the U.S., Histoplasmosis caused by H. capsulatum is estimated to have around 15,000 new infections and 9000 deaths among people living with Human Immunodeficiency Virus (HIV)-PLHIV. It has been estimated that about half a million people acquire an infection per year and 100,000 develop disseminated one. An adequate diagnostic test with high sensitivity & specificity needs to be considered. The treatment of the infection, along with co-infection with T.B. and Histoplasmosis, Pneumocystis jirovecii (PJ) and Histoplasmosis and HIV needs to be managed appropriately. WHO's priority to have access to rapid testing and availability of treatment drugs for Histoplasmosis is notable.
| Original language | English |
|---|---|
| Title of host publication | Histoplasmosis |
| Subtitle of host publication | From Diagnosis to Treatment |
| Publisher | Nova Science Publishers, Inc. |
| Pages | 173-189 |
| Number of pages | 17 |
| ISBN (Electronic) | 9798891132283 |
| ISBN (Print) | 9798891131293 |
| Publication status | Published - 27 Nov 2023 |
Keywords
- AIDS
- Amphotericin
- Antigen
- Diagnosis
- EIA
- HIV
- Histoplasmosis
- Itraconazole
- PLHIV
- Treatment
